Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A model for the apparent decrease in optical transmittance of the diabetic eye.

M L Daley1, R C Watzke, M C Riddle

  • 1Division of Neurosurgery, Oregon Health Sciences University, Portland 97201.

IEEE Transactions on Bio-Medical Engineering
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reply to the Letter to the Editor: Response to Concerns Raised on MRI Surveillance and Clinical Implications of ARIA in Disease Modifying Treatment.

The journal of prevention of Alzheimer's disease·2024
Same author

Initial Experiences with Amyloid-Related Imaging Abnormalities in Patients Receiving Aducanumab Following Accelerated Approval.

The journal of prevention of Alzheimer's disease·2023
Same author

Assessment of hypoglycaemia during basal insulin therapy: Temporal distribution and risk of events using a predefined or an expanded definition of nocturnal events.

Diabetes & metabolism·2017
Same author

Glycaemic control and hypoglycaemia with insulin glargine 300U/mL versus insulin glargine 100U/mL in insulin-naïve people with type 2 diabetes: 12-month results from the EDITION 3 trial.

Diabetes & metabolism·2017
Same author

Glycaemic control and hypoglycaemia with insulin glargine 300 U/mL compared with glargine 100 U/mL in Japanese adults with type 2 diabetes using basal insulin plus oral anti-hyperglycaemic drugs (EDITION JP 2 randomised 12-month trial including 6-month extension).

Diabetes & metabolism·2017
Same author

New insulin glargine 300 U/ml versus glargine 100 U/ml in Japanese people with type 2 diabetes using basal insulin and oral antihyperglycaemic drugs: glucose control and hypoglycaemia in a randomized controlled trial (EDITION JP 2).

Diabetes, obesity & metabolism·2015
Same journal

Highly Accelerated 1-mm Isotropic 3D Chemical Exchange Saturation Transfer MRI Using Wave-Co-CAIPI at 5 Tesla.

IEEE transactions on bio-medical engineering·2026
Same journal

Systematic Evaluation of Hip Exoskeleton Assistance Parameters for Enhancing Gait Stability During Ground Slip Perturbations.

IEEE transactions on bio-medical engineering·2026
Same journal

SleepConFormer: A Single-Channel EEG Framework for Sleep Staging and Consciousness Assessment in Patients with Disorders of Consciousness.

IEEE transactions on bio-medical engineering·2026
Same journal

Modeling Partial and Total Support of Left Ventricular Assist Device for Discrete Hemodynamic Control Framework.

IEEE transactions on bio-medical engineering·2026
Same journal

A Low-Cost Wearable TI-TACS Stimulator With Bipolar Quadratic-Boost Converter for Current Stimulation Validation in the Rat Brain.

IEEE transactions on bio-medical engineering·2026
Same journal

EMG-Based Gait Estimation Using Koopman-Inspired Method.

IEEE transactions on bio-medical engineering·2026
See all related articles

Diabetic patients show decreased ocular transmittance due to light scattering from increased plasma proteins in the retina. This study models these changes, confirming the role of glycosylated albumin in diabetic eye complications.

Area of Science:

  • Ophthalmology
  • Biophysics
  • Diabetic Retinopathy Research

Background:

  • Diabetes mellitus is associated with ocular changes affecting light transmittance.
  • Rayleigh light scattering by plasma proteins, particularly albumin, is a known biophysical phenomenon.
  • Accelerated lens yellowing and potential neural injury can occur in diabetic patients.

Purpose of the Study:

  • To compare observed changes in ocular transmittance in diabetic patients with model predictions.
  • To investigate the role of glycosylated albumin concentration in altered light scattering.
  • To determine if increased plasma proteins within the retina cause decreased optical transmittance.

Main Methods:

  • Selective chromatic adaptation used to measure critical flicker fusion (CFF) frequency thresholds.

Related Experiment Videos

  • Comparison of Ferry-Porter characteristics to age-specific control values.
  • Calculation of optical density changes and adjustment for lens yellowing.

    • Main Results:

    • Experimentally derived long-wavelength changes in optical density aligned with model predictions (95% confidence interval).
    • A specific range of glycosylated albumin concentration was determined to fit short-wavelength optical density changes.
    • The model successfully predicted long-wavelength changes based on short-wavelength data.

    Conclusions:

    • Observed decreases in optical transmittance in diabetes mellitus are supported by light scattering from increased retinal plasma proteins.
    • Glycosylated albumin concentration is a key factor in the observed optical density changes.
    • The findings support a biophysical model for understanding visual disturbances in diabetes.